from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2727c/miaA

LFCtreatmentdescriptionclass of inhibitor

0.380

Amikacinug/mL Amikacintranslation

0.218

Cap5-10ug/mL Capreomycintranslation

1.080

Rox10-50 ug/mL Roxithromycintranslation

0.405

SM2-5 ug/mL Streptomycintranslation

0.021

Tet5-10 ug/mL Tetracyclinetranslation

-0.181

Rif0.2-5ug/mL Rifampicintranscription

-0.799

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.868

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.377

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.212

CPZ10-50 ug/mL Chlorpromazinerespiration

2.233

Clofazimine10-13 ug/mL Clofaziminerespiration

0.295

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.078

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.373

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.388

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.573

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.617

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.894

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.115

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.136

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.916

KCN5-20 ug/mL Potassium cyaniderespiration

0.481

NaN30.2-2 mM Sodium aziderespiration

-0.180

Nigericin50 uM Nigericinrespiration

-0.145

TRC10-150 ug/mL Triclosanrespiration

-0.915

TRZ10-25 ug/mL Thioridazinerespiration

-0.709

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.035

menadione6-10 ug/mL Menadionerespiration

0.047

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.046

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.281

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.359

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.895

NRP_1Non-replicating persistence stage 1dosRassociated

-0.244

Amp0.2mg/mL AmpicillincellWall

-0.437

Cephalexin20-100 ug/mL CephalexincellWall

0.095

Cerulenin0.32-5 ug/mL CerulenincellWall

0.174

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.296

EMB10-20 ug/mL EthambutolcellWall

-0.058

Eta12-40 ug/mL EthionamidecellWall

-0.112

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.045

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.513

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.645

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.377

BZA0.12 mg/mL BenzamidearomaticAmides

0.352

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.283

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.138

H2O24 mM hydrogen peroxideDNAdamaging

-0.583

Levo10 ug/mL LevofloxacinDNAdamaging

-0.339

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.789

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.031

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.222

UVUV-irradiationDNAdamaging

0.670

ARP41-4 ug/mL Antitubercular compound ARP4?

0.012

Antimycin12.5-50 ug/mL Antimycin A?

-0.348

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.117

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.706

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.442

PA8240.2-2 ug/mL PA-824?

0.684

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.103

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.244

Verapamil50 uM Verapamil?

0.042

mercaptoethanol2 mM 2-Mercaptoethanol?

0.094

methoxatin10-20 ug/mL Methoxatin?